Geftinat is the brand name of the medicine gefitinib. It is to be used in patients of non-small cell lung cancer (NSCLC). Its most common side effects are skin related - rash, acne, dry skin & pruritis as also nausea, vomiting, diarrhoea, anorexia, asthaenia and weight loss. Thrombocytopaenia (low platelets) is not a documented side effect. The platelet counts will pick up once the malarial infection clears.